Decreased type IV collagen of skin and serum in patients with amyotrophic lateral sclerosis

Neurology

Volumn 51, Issue 1, 1998, Pages 114-120

  Ono, S ^a   Imai, T ^b   Takahashi, K ^c   Jinnai, K ^c   Yamano, T ^a   Nagao, K ^a   Shimizu, N ^a   Yamauchi, M ^d  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Chiba Higashi Hospital   (Japan)

^c Japan   (Japan)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

ADULT; AGED; AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; SKIN;

EID: 0031814592     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.114     Document Type: Article

References (37)

1. Ono S, Toyokura Y, Mannen T, Ishibashi Y. Amyotrophic lateral sclerosis: histological, histochemical, and ultrastructural abnormalities of skin. Neurology 1986;36:948-956.
2. Ono S, Mechanic GL, Yamauchi M. Amyotrophic lateral sclerosis: unusually low content of collagen in skin. J Neurol Sci 1990;100:234-237.
3. Ono S, Yamauchi M. Cross-linking of skin in patients with amyotrophic lateral sclerosis. Ann Neurol 1992;31:305-310.
4. Ono S, Yamauchi M. Amyotrophic lateral sclerosis: increased solubility of skin collagen. Neurology 1992;42:1535-1539.
5. Timpl R, Wiedemann H, van Delden V, Furthmayr H, Kühn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981;120: 203-211.
6. Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983;49:636-649.
7. Bornstein P, Sage H. Structurally distinct collagen types. Annu Rev Biochem 1980;49:957-1003.
8. Kefalides NA. Structure and biosynthesis of basement membrane. Int Rev Connect Tissue Res 1973;6:63-104.
9. Risteli J, Rohde H, Timpl R. Sensitive radioimmunoassays for 7S collagen and laminin: application to serum and tissue studies of basement membranes. Anal Biochem 1981;113: 372-378.
10. Niemelä O, Risteri L, Sotaniemi EA, Risteli J. Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 1985;15:132-137.
11. Högemann B, Voss B, Altenwerth FJ, Schneider M, Rauterberg J, Gerlach U. Concentrations of 7S collagen and laminin P1 in sera of patients with diabetes mellitus. Klin Wochenschr 1986;64:382-385.
12. Högemann B, Balleisen L, Rauterberg J, Voss B, Gerlach U. Basement membrane components (7S collagen, laminin P1) are increased in sera of diabetics and activate platelets in vitro. Haemostasis 1986;16:428-432.
13. Matsumoto E. Foreknowledge of liver fibrosis: development of immunoassay system for serum collagen peptides with monoclonal antibody. J Wakayama Med Soc 1988;39:87-106.
14. Caroscio JT, Cohen JA, Zawodniak J, et al. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis. Neurology 1986;16:141-145.
15. Patten BM, Harati Y, Acosta L, Jung SS, Feimus MT. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol 1978;3:305-309.
16. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
17. Vázquez F, Palacios S, Alemañ N, Guerrero F. Changes of the basement membrane and type IV collagen in human skin during aging. Maturitas 1996;25:209-215.
18. Suou T, Yamada S, Kobayashi J, Hoshino U, Nishimuki E, Kawasaki H. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury. Hepatology 1993;18:809-815.
19. Timpl R, Dziadek M. Structure, development, and molecular pathology of basement membranes. Int Rev Exp Pathol 1986; 29:1-112.
20. Kefalides NA, Alper R, Clark CC. Biochemistry and metabolism of basement membranes. Int Rev Cytol 1979;61:167-228.
21. Betz P, Nerlich A, Wilske J, et al. The time-dependent rearrangement of the epithelial basement membrane in human skin wounds: immunohistochemical localization of collagen IV and VII. Int J Legal Med 1992;105:93-97.
22. Yurchenco PD, Furthmayr H. Self-assembly of basement membrane collagen. Biochemistry 1984;23:1839-1850.
23. Charonis AS, Tsilibary EC, Yurchenco PD, Furthmayr H. Binding of laminin to type IV collagen: a morphological study. J Cell Biol 1985;100:1848-1853.
24. Laurie GW, Bing JT, Kleinman HK, et al. Localization of binding sites for laminin, heparan sulfate proteoglycan and fibronectin on basement membrane (type IV) collagen. J Mol Biol 1986;189:205-216.
25. Mihara M, Miura M, Suyama Y, Shimano S. Scanning electron microscopy of the epidermal lamina densa in normal human skin. J Invest Dermatol 1992;99:572-578.
26. Rigal C, Pieraggi MT, Vicent C, Prost C, Bouisou H, Serre G. Healing of full-thickness cutaneous wounds in the pig. I. Immunohistochemical study of epidermodermal junction regeneration. J Invest Dermatol 1991;96:777-785.
27. Tsutsumi M, Urashima S, Matsuda Y, Takase S, Takada A. Changes in type IV collagen content in livers of patients with alcoholic liver disease. Hepatology 1993;17:820-827.
28. Brincat M, Versi E, Moniz CF, Magos A, de Trafford J, Studd JW. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987;70:123-127.
29. Castelo-Branco C, Duran M, González-Merlo J. Skin collagen changes related to age and hormone replacement therapy. Maturitas 1992;15:113-119.
30. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metallo-proteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology 1994;20:780-787.
31. Suou T, Yamada S, Hosho K, Yoshikawa N, Kawasaki H. Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease. Hepatology 1996;23: 1154-1158.
32. Yabu K, Kiyosawa K, Mori H, et al. Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C. Scand J Gastroenterol 1994;29:474-479.
33. Inomata S, Itoh M, Sato T. Difference of serum levels of type IV collagen 7S between early or overt nephropathy and nondiabetic renal disease in diabetic patients with micro- or macroalbuminuria. Nephron 1996;73:601-605.
34. Matsumoto E, Matsumoto G, Ooshima A, et al. Serum type IV collagen concentrations in diabetic patients with microangiopathy as determined by enzyme immunoassay with monoclonal antibodies. Diabetes 1990;39:885-890.
35. Ohsato K, Shimizu M, Sugihara N, et al. Type IV collagen in hypertrophic cardiomyopathy. Jpn Heart J 1994;35:311-321.
36. Yudoh K, Matsui H, Kanamori M, Ohmori K, Tsuji H, Tatezaki S. Serum levels of laminin, type IV collagen and type III procollagen peptide as markers for detection of metastasis. Jpn J Cancer Res 1994;85:1263-1269.
37. Ambiru S, Miyazaki M, Nakagawa K, Nakajima N. Increased serum type IV collagen 7-S levels in patients with hepatic metastasis. Am J Gastroenterol 1995;90:783-787.